These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7478129)

  • 1. Elimination of gadolinium-DTPA by peritoneal dialysis.
    Dörsam J; Knopp MV; Schad L; Piesche S; Carl S; Oesingmann N
    Nephrol Dial Transplant; 1995; 10(7):1228-30. PubMed ID: 7478129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of gadolinium-DTPA in chronic renal insufficiency requiring dialysis].
    Krahe T; Götz R; Lackner K; Haustein J; Klemenz U; Landwehr P; Heidbreder E; Schuhmann-Giampieri G
    Rofo; 1992 Jun; 156(6):523-6. PubMed ID: 1617171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of double-contrast enhanced porcine myocardial infarction. Correlation with microdialysis.
    Nilsson S; Wikström M; Ericsson A; Wikström G; Waldenström A; Oksendal A; Hemmingsson A
    Acta Radiol; 1995 Jul; 36(4):346-52. PubMed ID: 7619610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The rapid magnetic resonance tomography measurement of the contrast medium dilution kinetics (gadolinium-DTPA) in a circulatory phantom].
    Böck JC; Sander B; Frank J; Schörner W
    Rofo; 1991 Sep; 155(3):267-71. PubMed ID: 1912546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and stability of caldiamide sodium in rats.
    Okazaki O; Kurata T; Yoshioka N; Hakusui H
    Arzneimittelforschung; 1996 Jan; 46(1):79-83. PubMed ID: 8821523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging.
    Nakashima R; Yamashita Y; Tomiguchi S; Tsuji A; Takahashi M
    Radiat Med; 1996; 14(5):251-6. PubMed ID: 8988504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative magnetic resonance imaging in assessment of the blood-retinal barrier.
    Plehwe WE; McRobbie DW; Lerski RA; Kohner EM
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):663-70. PubMed ID: 3366561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can gadolinium be safely given in renal failure?
    Weissleder R
    AJR Am J Roentgenol; 1996 Jul; 167(1):278-9. PubMed ID: 8659405
    [No Abstract]   [Full Text] [Related]  

  • 10. Nonlinear pharmacokinetic modeling of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G
    Arzneimittelforschung; 1993 Sep; 43(9):1020-4. PubMed ID: 8240452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Visualization of multiple neurofibromas using gadolinium-DTPA assisted MRT: a case report].
    Kaminsky S; Schulz B
    Rontgenblatter; 1988 Dec; 41(12):492-4. PubMed ID: 3145555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadodiamide injection. First human experience with the nonionic magnetic resonance imaging enhancement agent.
    Van Wagoner M; Worah D
    Invest Radiol; 1993 Mar; 28 Suppl 1():S44-8. PubMed ID: 8486503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of gadolinium-DTPA-BMA-enhanced reperfused and nonreperfused porcine myocardial infarction.
    Nilsson S; Wikström G; Ericsson A; Wikström M; Waldenström A; Hemmingsson A
    Acta Radiol; 1995 Nov; 36(6):633-40. PubMed ID: 8519575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine.
    Vexler VS; Clément O; Brasch RC
    Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273
    [No Abstract]   [Full Text] [Related]  

  • 15. [The magnetic resonance assessment of craniofacial fibrous dysplasia. The completion of the study with gadolinium administration and magnetic resonance angiography].
    Di Girolamo M; Scipioni A; Laghi A; Corsetti A; Ferone E; Pavone P; Passariello R
    Radiol Med; 1996 Mar; 91(3):313-6. PubMed ID: 8628950
    [No Abstract]   [Full Text] [Related]  

  • 16. Gd-DTPA-enhanced MR imaging in mediastinal Hodgkin's disease.
    Forsgren G; Nyman R; Glimelius B; Hagberg H; Rehn S; Hemmingsson A
    Acta Radiol; 1994 Nov; 35(6):564-9. PubMed ID: 7946679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of Gadolinium-DTPA in the assessment of renal tumors with magnetic resonance].
    Torricelli P; Montanari N; De Santis M; Pollastri C
    Radiol Med; 1994 May; 87(5):653-61. PubMed ID: 8008898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA].
    Pronin IN; Kornienko VN
    Zh Vopr Neirokhir Im N N Burdenko; 1995; (2):16-7. PubMed ID: 7625134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadodiamide in renal transplant patients: effects on renal function and usefulness as a glomerular filtration rate marker.
    Berg KJ; Lundby B; Reinton V; Nordal KP; Rootwelt K; Smith HJ
    Nephron; 1996; 72(2):212-7. PubMed ID: 8684529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of gadolinium-diethylene triamine pentaacetic acid in human kidney--study on proper time for dynamic magnetic resonance imaging of the human kidney on low and high magnetic fields.
    Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T; Tanikawa T; Sato S
    Tohoku J Exp Med; 1993 Oct; 171(2):119-28. PubMed ID: 8128480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.